These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 8751034)

  • 41. Single- and multiple-dose mibefradil pharmacokinetics in normal and hypertensive subjects.
    Welker HA
    J Pharm Pharmacol; 1998 Sep; 50(9):983-7. PubMed ID: 9811158
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship of age to the pharmacokinetics of early drug distribution: the concurrent disposition of thiopental and indocyanine green.
    Avram MJ; Krejcie TC; Henthorn TK
    Anesthesiology; 1990 Mar; 72(3):403-11. PubMed ID: 2310019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of thiopentone enantiomers following intravenous injection or prolonged infusion of rac-thiopentone.
    Cordato DJ; Gross AS; Herkes GK; Mather LE
    Br J Clin Pharmacol; 1997 Apr; 43(4):355-62. PubMed ID: 9146846
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A population pharmacokinetic/pharmacodynamic analysis of regadenoson, an adenosine A2A-receptor agonist, in healthy male volunteers.
    Gordi T; Frohna P; Sun HL; Wolff A; Belardinelli L; Lieu H
    Clin Pharmacokinet; 2006; 45(12):1201-12. PubMed ID: 17112296
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of the novel anticonvulsant HEPP after single intravenous administration of three different doses in dogs.
    Gómez LE; Lehmann PA
    Biopharm Drug Dispos; 1995 Mar; 16(2):105-12. PubMed ID: 7780044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects.
    Rohatagi S; Gillen M; Aubeneau M; Jan C; Pandit B; Jensen BK; Rhodes G
    Int J Clin Pharmacol Ther; 2001 Mar; 39(3):126-34. PubMed ID: 11396753
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techique.
    Heikkinen H; Saraheimo M; Antila S; Ottoila P; Pentikäinen PJ
    Eur J Clin Pharmacol; 2001; 56(11):821-6. PubMed ID: 11294372
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single intravenous and multiple dose pharmacokinetics of gentamicin in healthy llamas.
    Lackey MN; Belknap EB; Greco DS; Fettman MJ
    Am J Vet Res; 1996 Aug; 57(8):1193-9. PubMed ID: 8836374
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies.
    Chen CL; Levine A; Rao A; O'Neill K; Messinger Y; Myers DE; Goldman F; Hurvitz C; Casper JT; Uckun FM
    J Clin Pharmacol; 1999 Dec; 39(12):1248-55. PubMed ID: 10586390
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraperitoneal administration of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide in the mouse: bioavailability, pharmacokinetics and toxicity after a single dose.
    Evans SM; Young D; Robertson IG; Paxton JW
    Cancer Chemother Pharmacol; 1992; 31(1):32-6. PubMed ID: 1458557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Safety, tolerability, and pharmacokinetics of sumatriptan in healthy subjects following ascending single intranasal doses and multiple intranasal doses.
    Moore KH; Hussey EK; Shaw S; Fuseau E; Duquesnoy C; Pakes GE
    Cephalalgia; 1997 Jun; 17(4):541-50. PubMed ID: 9209776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Population pharmacokinetics and pharmacodynamics of thiopental: the effect of age revisited.
    Stanski DR; Maitre PO
    Anesthesiology; 1990 Mar; 72(3):412-22. PubMed ID: 2310020
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pharmacokinetic-pharmacodynamic model for quantal responses with thiopental.
    Shanks CA; Avram MJ; Krejcie TC; Henthorn TK; Gentry WB
    J Pharmacokinet Biopharm; 1993 Jun; 21(3):309-21. PubMed ID: 8258770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic Properties and Tolerability of Cycloserine Following Oral Administration in Healthy Chinese Volunteers: A Randomized, Open-Label, Single- and Multiple-Dose 3-Way Crossover Study.
    Zhou H; Wu G; Hu X; Zhu M; Zhai Y; Liu J; Shentu J; Wu L
    Clin Ther; 2015 Jun; 37(6):1292-300. PubMed ID: 25869627
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selection of dosing regimen with WST11 by Monte Carlo simulations, using PK data collected after single IV administration in healthy subjects and population PK modeling.
    Fabre MA; Fuseau E; Ficheux H
    J Pharm Sci; 2007 Dec; 96(12):3444-56. PubMed ID: 17854075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics and bioavailability of tolfenamic acid in sheep.
    Corum O; Corum DD; Er A; Yildiz R; Uney K
    J Vet Pharmacol Ther; 2018 Dec; 41(6):871-877. PubMed ID: 30084126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.